NewAmsterdam Pharma
NAMS
NAMS
126 hedge funds and large institutions have $2.28B invested in NewAmsterdam Pharma in 2025 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 32 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $2.53B → $2.28B (-$256M)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
13% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 30
Holders
126
Holding in Top 10
7
Calls
$9.46M
Puts
$6.37M
Top Buyers
| 1 | +$118M | |
| 2 | +$26.5M | |
| 3 | +$25.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$19.7M |
| 5 |
JP Morgan Chase
New York
|
+$19M |
Top Sellers
| 1 | -$9.82M | |
| 2 | -$8.7M | |
| 3 | -$8.35M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$7.41M |
| 5 |
GC
GMT Capital
Atlanta,
Georgia
|
-$7.33M |